Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
Marizomib，一种适用于所有情况的蛋白酶体抑制剂：临床前概况和临床试验框架
期刊:Current Cancer Drug Targets
影响因子:3.5
doi:10.2174/156800911794519716
Potts, B C; Albitar, M X; Anderson, K C; Baritaki, S; Berkers, C; Bonavida, B; Chandra, J; Chauhan, D; Cusack, J C Jr; Fenical, W; Ghobrial, I M; Groll, M; Jensen, P R; Lam, K S; Lloyd, G K; McBride, W; McConkey, D J; Miller, C P; Neuteboom, S T C; Oki, Y; Ovaa, H; Pajonk, F; Richardson, P G; Roccaro, A M; Sloss, C M; Spear, M A; Valashi, E; Younes, A; Palladino, M A
